Home
Search
BIO International Convention   |   June 3-6, 2024

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Kimberly Ha
FOUNDER, KKH ADVISORS
From C-Suite to VC: Lessons from the Biotech Trenches
San Juan, Not Applicable, Puerto Rico
Magali Haas, MD, PhD
CEO AND PRESIDENT, COHEN VETERANS BIOSCIENCE
Beyond Drug Approvals: Clinical Trials that Actually Advance CNS Innovation
New York, New York, United States
Placeholder Photo
Sepideh Haghpanah, MD
DIVISION OF RARE DISEASES AND MEDICAL GENETICS OFFICE OF RARE DISEASES, PEDIATRICS, UROLOGIC AND REPRODUCTIVE MEDICINE, OND, CDER
40 years of the Orphan Drug Act, the Rare Disease Endpoint Advancement (RDEA) Pilot Program, and Transforming Rare Disease Development
Brett Hall, PhD
CHIEF SCIENTIFIC OFFICER, IMMUNEERING CORPORATION
Immuneering Corporation
Cambridge, Massachusetts, United States
Jeffery Halter
PRESIDENT, YWOMEN
Belonging in Biotech: How to Advance Greater Inclusion Across the Biotech Workforce
Placeholder Photo
Bonnie Hammer
SENIOR VICE PRESIDENT, RESEARCH & DEVELOPMENT, INVENRA INC.
Platforms & Products: Creating Collaborations That Turn Technologies into Therapeutics
Madison, Wisconsin, United States
Grace Han McMahon, JD
ASSOCIATE VICE PRESIDENT AND HEAD OF MERCK’S BD&L PACIFIC INNOVATION HUB, MERCK
Platforms & Products: Creating Collaborations That Turn Technologies into Therapeutics
South San Francisco, California, United States
Morgan Hanger
DIRECTOR OF STRATEGIC PROGRAMS, CLINICAL TRIALS TRANSFORMATION INITIATIVE
Meta-Collaboration to Improve Decentralized Trial Excellence: Updates from the Collaboration Landscape
Nadia Haque, ACA
EXECUTIVE DIRECTOR, RESEARCH TECHNOLOGIES, PHARMA PARTNERING, GENENTECH
Genentech, a Member of the Roche Group
South San Francisco, California, United States
Kouki Harasaki, PhD, MBA
FOUNDING/MANAGING PARTNER, BIOLUMINESCENCE VENTURES
Emerging RNA Therapy Platforms: The Next Generation Genetic Medicines
Oncology Drug Discovery: Novel Approaches To Drug Discovery
The Next Generation of Gene Editing Therapeutic Technologies